Salvatore Michele Carnazzo

Salvatore Michele Carnazzo


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2024 in Journal of Child Neurology
Verified
Journal Article
Closed access
SCSalvatore Michele Carnazzo
Salvatore Michele Carnazzo
DBDesirèe Balconara
Desirèe Balconara
FCFrancesco Caruso
Francesco Caruso
GCGiusi Maria Caltabiano
Giusi Maria Caltabiano
Kabuki syndrome is a rare congenital disorder characterized by a distinctive combination of craniofacial features, developmental anomalies, and intellectual disabilities. This study aims to provide a comprehensive exploration of Kabuki syndrome through a meticulous case series analysis focusing on its clinical features and genetic underpinnings. A cohort of 9 Kabuki syndrome patients was identified through a retrospective examination of medical records spanning from 1996 to 2022. These patients underwent various clinical assessments, radiologic investigations, neuropsychological evaluations, and targeted genetic analyses, specifically focusing on the KMT2D and KDM6A genes. The median age of diagnosis was approximately 4.7 years, with a male-to-female ratio of 6:3. Prominent clinical characteristics included distinctive facial features such as arched eyebrows, elongated eyelashes, ear abnormalities, fingertip pads, nasolabial anomalies, and oral alterations. Ophthalmologic and otologic manifestations were notable, alongside a spectrum of cardiovascular, gastrointestinal, and endocrine aberrations. The prevalence of neuropsychological disorders highlighted the cognitive and behavioral challenges experienced by Kabuki syndrome patients. Genetic investigations confirmed the involvement of variants in the KMT2D and KDM6A genes in the pathogenesis of Kabuki syndrome. In conclusion, this study emphasizes the importance of precise diagnosis, the adoption of a multidisciplinary care approach, and the tailored interventions for individuals affected by Kabuki syndrome. Furthermore, it underscores the need for continued research efforts to unravel the genetic intricacies and molecular mechanisms underlying this enigmatic syndrome.

15 November 2024 in Radiology Case Reports
Verified
Journal Article
Open access
SCSalvatore Michele Carnazzo
Salvatore Michele Carnazzo
CCCarla Cerruto
Carla Cerruto
FCFrancesco Fabrizio Comisi
Francesco Fabrizio Comisi
Tuberculosis (TB) remains a significant global health challenge, particularly within pediatric populations. This article reports the case of a 7-year-old female patient admitted with massive fibrinous pleural effusion secondary to TB, highlighting the key role of ultrasound in disease monitoring and therapeutic guidance. The patient presented with fever, cough, and abdominal pain. Imaging confirmed the presence of pleural effusion and lymphadenopathy. Serial ultrasound assessments demonstrated superior sensitivity compared to CT in characterizing the pleural effusion, leading to the initiation of intrapleural urokinase therapy under ultrasound guidance. The treatment resulted in the successful dissolution of fibrin septations and marked clinical improvement. The discussion explores the diagnostic advantages of ultrasound in pediatric TB, its effectiveness in monitoring therapeutic response, and the utility of localized fibrinolytic therapy. This case highlights the value of ultrasound as a cost-effective, noninvasive, radiation-free tool in the management of pediatric TB, advocating for its increased integration into routine pediatric care.

1 April 2026 in Cells
Verified
Journal Article
Open access
PDF file
SCSalvatore Michele Carnazzo
Salvatore Michele Carnazzo
FAFabio Allia
Fabio Allia
Alice FotiAlice Foti
Alice Foti
Marilena BrigliaMarilena Briglia
Marilena Briglia
MMMarcello Maida
Marcello Maida
APAndrea Domenico Praticò
Andrea Domenico Praticò
Changes in microbial composition during early infancy by various factors (mode of delivery, nutritional practices, antibiotic usage, and environmental influences) have been correlated with observable variances in cognitive abilities, temperament, stress response, and the predisposition to neurodevelopmental disorders. Consequently, microbiota-targeted interventions such as probiotics, prebiotics, and synbiotics are being explored as avenues to enrich beneficial microbial taxa, enhance short-chain fatty acid production, fortify mucosal immunity, and mitigate inflammatory responses during these critical periods. Preclinical research, primarily in experimental animal models, has demonstrated a causal link between microbiota composition and developmental processes such as myelination, synaptic plasticity, and socio-emotional behaviors, whereas human evidence remains largely associative and heterogeneous. A notable gap exists in the current literature, which typically centers on gastrointestinal, psychiatric, or preterm outcomes, without a focused investigation into neurodevelopmental assessments within the first three years. To bridge this gap, we conducted a systematic review and meta-analysis of randomized controlled trials assessing the impact of probiotics, prebiotics, and synbiotics on neurodevelopment and behavior in infants aged 0–36 months. Our primary objective was to establish whether microbiota-targeted strategies confer discernible neurodevelopmental benefits, alongside elucidating the mechanisms underpinning the relationship between microbial modulation and early brain development.

17 April 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SCSalvatore Michele Carnazzo
Salvatore Michele Carnazzo
VFVassilios Fanos
Vassilios Fanos
The microbiota–gut–brain axis (MGBA) is a complex bidirectional communication network integrating neural, endocrine, immune, and metabolic pathways linking intestinal microbiota to central nervous system function. Increasing evidence indicates that microbiota-derived signals are critical regulators of neurodevelopment and may contribute to vulnerability to neurodegenerative disorders across the lifespan. In this narrative review, we synthesize experimental and clinical evidence to define the key biological mechanisms underlying microbiota–brain interactions. Converging data indicate that immune activation, barrier dysfunction, and microbial metabolites, particularly short-chain fatty acids and tryptophan-derived compounds, represent central mediators linking gut dysbiosis to neuroinflammatory and neurodegenerative processes. Early-life microbial perturbations, driven by factors such as antibiotic exposure, diet, and psychosocial stress, appear to induce long-term immunometabolic programming that may increase susceptibility to neurological disorders later in life. Clinical studies consistently associate dysbiosis with neurodevelopmental conditions and major neurodegenerative diseases, including Alzheimer’s disease and Parkinson’s disease; however, causal relationships remain incompletely defined due to heterogeneity and the predominance of observational data. Overall, the available evidence supports a lifespan model in which microbiota-driven immune and metabolic dysregulation contributes to both early neurodevelopmental trajectories and late-life neurodegeneration. While microbiome-based biomarkers and therapeutic strategies show promise, their clinical translation requires validation in longitudinal and interventional studies.

18 June 2026 in Journal of Neuroimmunology
Verified
Journal Article
Open access
SCSalvatore Michele Carnazzo
Salvatore Michele Carnazzo
AVAlessandro Vitello
Alessandro Vitello
FAFabio Allia
Fabio Allia
AGAdriana Carol Eleonora Graziano
Adriana Carol Eleonora Graziano
APAndrea Domenico Praticò
Andrea Domenico Praticò
MMMarcello Maida
Marcello Maida
Early life represents a critical window for maturation of the gut microbiota, mucosal immunity, and neuroimmune pathways underpinning the gut-brain axis (GBA). Probiotic, prebiotic, and synbiotic interventions have been proposed to modulate these processes; however, their mechanistic effects on GBA-relevant biomarkers in humans remain unclear. We conducted a systematic review of randomized controlled trials (RCTs) evaluating microbiota-directed interventions in infants aged 0-36 months, focusing on biological pathways implicated in gut-brain communication. Searches of PubMed/MEDLINE, Scopus, and Web of Science identified six eligible RCTs including 1148 randomized participants, of whom 923 contributed data to at least one GBA-relevant biomarker. Outcomes were synthesized across six mechanistic domains: intestinal microbiota composition and functional proxies, microbial metabolites, mucosal immunity, systemic cytokines, intestinal inflammation and permeability, and hypothalamic-pituitary-adrenal (HPA) axis activity. Across trials, interventions were associated with localized mucosal effects, including selective enrichment of Bifidobacterium and Lactobacillus, modest reductions in fecal pH, and modest, variably reported increases in fecal secretory sIgA. In contrast, short-chain fatty acids (SCFAs) were inconsistently reported and showed no robust between-group differences. Systemic cytokines, fecal calprotectin, permeability markers, basal salivary cortisol, and neurodevelopmental outcomes remained unchanged. Methodological heterogeneity, frequent values below assay detection limits, and developmental variability precluded quantitative meta-analysis. Available RCT evidence, although limited and heterogeneous, suggests that early-life microbiota-directed interventions may be associated with compartmentalized microbial and mucosal immune modulation without measurable propagation to systemic neuroimmune or neurodevelopmental pathways in healthy or mildly symptomatic infants. These findings support a model of developmental neuroimmune gating within the early-life GBA, defined here as the physiological restriction of signal propagation from mucosal to systemic and central pathways during early life, and highlight the need for standardized biomarker frameworks, dynamic neuroendocrine assessments, and studies in higher-risk populations to clarify mechanistic relevance.

15 June 2026 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
SCSalvatore Michele Carnazzo
Salvatore Michele Carnazzo
DBDesirèe Balconara
Desirèe Balconara
MQMoreno La Quatra
Moreno La Quatra
APAndrea Domenico Praticò
Andrea Domenico Praticò